Vikas Dharnidharka(@Vikas_R_D) 's Twitter Profileg
Vikas Dharnidharka

@Vikas_R_D

Pediatric Nephrology Division Chief and transplant researcher, Washington University in St Louis. Any opinions are mine alone and are not medical advice.

ID:760832603062755328

calendar_today03-08-2016 13:40:03

1,5K Tweets

1,3K Followers

190 Following

Vikas Dharnidharka(@Vikas_R_D) 's Twitter Profile Photo

Sponsorship and mentorship can make a huge difference to someone's career! I know they did for me - now glad to pay it forward. Thank you Washington U. Med Dean Perlmutter and Associate Dean Renée Shellhaas, MD, MS for creating such an award and for this humbling honor!

account_circle
Vikas Dharnidharka(@Vikas_R_D) 's Twitter Profile Photo

Wow! Though post-transplant lymphoproliferative disorders (PTLDs) have been my passion for 25+ years, never did I think I would have a worldwide citation and impact ranking like this! Very humbling, but still so much to do in this field.

Wow! Though post-transplant lymphoproliferative disorders (PTLDs) have been my passion for 25+ years, never did I think I would have a worldwide citation and impact ranking like this! Very humbling, but still so much to do in this field.
account_circle
Vikas Dharnidharka(@Vikas_R_D) 's Twitter Profile Photo

After gatecrashing this event for many years, glad to now be a regular official invitee! I feel that a division chief perspective is important at such events.

account_circle
Vikas Dharnidharka(@Vikas_R_D) 's Twitter Profile Photo

Congratulations to Dr. Samir El-Dahr on being the 2024 recipient of the American Academy of Pediatrics Henry Barnett lifetime achievement award winner! A most deserving addition to an illustrious list! Samir Sayem El-Dahr

Congratulations to Dr. Samir El-Dahr on being the 2024 recipient of the @AmerAcadPeds Henry Barnett lifetime achievement award winner! A most deserving addition to an illustrious list! @seldahr
account_circle
Vikas Dharnidharka(@Vikas_R_D) 's Twitter Profile Photo

5/5 With an electronic-only journal, rejection rates don’t have to be > 90%, -> faster publication. Impact factor would then be the quality criterion. Pvt companies and med societies still would get impactful research–enough out there to keep all happy. Please be kind in replies.

account_circle
Vikas Dharnidharka(@Vikas_R_D) 's Twitter Profile Photo

4/5 The journal would make lots of money even with no open access publication fees and after paying reviewers – monies that could be ploughed back into more research grants. The science would be immediately accessible to all worldwide.

account_circle
Vikas Dharnidharka(@Vikas_R_D) 's Twitter Profile Photo

3/5 Access to much of the published science is restricted for at least 12 months. I suggest: NIH should start their own electronic-only Journal of the National Institutes of Health. NIH would have right of first refusal for any manuscript that includes research funded by NIH.

account_circle
Vikas Dharnidharka(@Vikas_R_D) 's Twitter Profile Photo

2/5 These publishers all make > US$2billion/yr, though they did not fund the research or write the papers. Most don’t pay the peer reviewers. High tier journals have > 90% rejection rates. Authors budget publication fees in their grants, also coming out of taxpayer monies.

account_circle
Vikas Dharnidharka(@Vikas_R_D) 's Twitter Profile Photo

1/5 While at the @PASmeeting, I reflected on how medical journal publishing needs to change.
Much of the research in the USA is funded by the NIH (via taxpayers), foundations or universities. Authors then pay huge fees to private medical journals to get their science published.

account_circle
Vikas Dharnidharka(@Vikas_R_D) 's Twitter Profile Photo

We provide summer scholars programs and pilot grants for the entire community that is interested in advancing pediatric nephrology! Thank you NIDDK

account_circle